Hamilton LaneHLNE
HLNE
About: Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.
Employees: 700
0
Funds holding %
of 7,139 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
97% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 37
8% more funds holding
Funds holding: 318 [Q3] → 344 (+26) [Q4]
8% more repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 113
0.42% less ownership
Funds ownership: 96.88% [Q3] → 96.45% (-0.42%) [Q4]
10% less capital invested
Capital invested by funds: $6.61B [Q3] → $5.97B (-$649M) [Q4]
10% less call options, than puts
Call options by funds: $1.8M | Put options by funds: $2.01M
50% less funds holding in top 10
Funds holding in top 10: 4 [Q3] → 2 (-2) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$139
8%
downside
Avg. target
$159
5%
upside
High target
$169
12%
upside
3 analyst ratings
0 positive
0%
2 neutral
67%
1 negative
33%
Keefe, Bruyette & Woods Kyle Voigt 71% 1-year accuracy 22 / 31 met price target | 11%upside $168 | Market Perform Maintained | 5 Feb 2025 |
Wells Fargo Michael Brown 52% 1-year accuracy 31 / 60 met price target | 12%upside $169 | Equal-Weight Maintained | 5 Feb 2025 |
Goldman Sachs Alexander Blostein 67% 1-year accuracy 29 / 43 met price target | 8%downside $139 | Sell Downgraded | 6 Jan 2025 |
Financial journalist opinion
Based on 14 articles about HLNE published over the past 30 days
Neutral
Business Wire
1 day ago
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women's Health and Dermatology
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma's Board of Directors has unanimously recomm.
Neutral
Business Wire
2 days ago
73 Strings Secures $55m Series B Led by Growth Equity at Goldman Sachs Alternatives
NEW YORK--(BUSINESS WIRE)--73 Strings, the financial intelligence platform using AI to revolutionize data extraction, monitoring, and valuation for the $17.6 Trillion AUM Alternative Asset Management space, has successfully closed a $55m Series B. The round was led by Growth Equity at Goldman Sachs Alternatives, with continued investment from Blackstone Innovations Investments and participation from Golub Capital, Hamilton Lane (Nasdaq: HLNE) and Broadhaven Ventures, solidifying 73 Strings' rep.
Neutral
Business Wire
1 week ago
PSG Closes Two Funds Totaling $8 Billion
BOSTON, MA--(BUSINESS WIRE)--PSG, a leading growth equity firm that specializes in partnering with software and technology-enabled services companies to capitalize on transformational growth, today announced that it has closed two new funds, totaling $8 billion in capital commitments. PSG's sixth North American flagship fund, PSG VI, closed with $6 billion in capital commitments, surpassing its $4.7 billion predecessor fund. The fund received commitments from new and existing investors, includi.
Positive
Seeking Alpha
1 week ago
Hamilton Lane Q3 Earnings: Slowing Momentum, But Shares Remain Expensive
Q3 results showed revenue up 34% year over year, coupled with strong overall profitability, both benefiting from higher incentive fees. Underlying growth in assets under management/advisement was muted, up just 6% year over year. While growth is expected to slowdown in the coming quarters, shares remain richly valued at 34.6 times earnings.
Neutral
PRNewsWire
1 week ago
Hamilton Lane Announces Pricing of Public Offering of Class A Common Stock
CONSHOHOCKEN, Pa. , Feb. 10, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced the pricing of an underwritten public offering by Hamilton Lane and a selling stockholder of 1,572,536 shares of Class A common stock, in the aggregate, for gross proceeds of approximately $252 million.
Neutral
PRNewsWire
1 week ago
Hamilton Lane Announces Public Offering of Class A Common Stock
CONSHOHOCKEN, Pa. , Feb. 10, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced that it has commenced an underwritten public offering of 1,572,536 shares of Class A common stock, in the aggregate, to be sold by Hamilton Lane and a selling stockholder, subject to market and other conditions.
Neutral
Business Wire
1 week ago
Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #cosettepharma--Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations.
Neutral
PRNewsWire
2 weeks ago
Hamilton Lane Closes Inaugural Venture Access Fund with Over $615 Million in Commitments, Exceeding Target Fund Size
The Fund features a high-quality venture portfolio targeting top-performing, oversubscribed funds and companies CONSHOHOCKEN, Pa. , Feb. 6, 2025 /PRNewswire/ -- Leading global private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced the final close of its Venture Access Fund ("VAF" or "the Fund"), which successfully exceeded its target fund size, raising $615.3 million in commitments.
Neutral
Seeking Alpha
2 weeks ago
Hamilton Lane Incorporated (HLNE) Q3 2025 Earnings Conference Call Transcript
Hamilton Lane Incorporated (NASDAQ:HLNE ) Q3 2025 Earnings Conference Call February 4, 2025 11:00 AM ET Company Participants John Oh - Head of Shareholder Relations Erik Hirsch - Co-CEO Jeff Armbrister - CFO Conference Call Participants Ken Worthington - JPMorgan Alex Blostein - Goldman Sachs Michael Cyprys - Morgan Stanley Mike Brown - Wells Fargo Aidan Hall - KBW Operator Good morning, ladies and gentlemen, and welcome to the Hamilton Lane Fiscal Third Quarter 2025 Earnings Call. At this time, all lines are in a listen-only mode.
Positive
Zacks Investment Research
2 weeks ago
Hamilton Lane (HLNE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Hamilton Lane (HLNE) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Charts implemented using Lightweight Charts™